

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 9.97985310 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 9.66608932 |
| 3 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 9.66608932 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.51070924 |
| 5 | drug transport (GO:0015893) | 8.38531194 |
| 6 | cell adhesion mediated by integrin (GO:0033627) | 8.13143016 |
| 7 | phosphate ion transport (GO:0006817) | 7.91014672 |
| 8 | neuronal stem cell maintenance (GO:0097150) | 7.74763306 |
| 9 | organic cation transport (GO:0015695) | 7.58227679 |
| 10 | lysine metabolic process (GO:0006553) | 7.48558699 |
| 11 | lysine catabolic process (GO:0006554) | 7.48558699 |
| 12 | detection of temperature stimulus (GO:0016048) | 6.80506801 |
| 13 | quaternary ammonium group transport (GO:0015697) | 6.73592999 |
| 14 | phosphate ion transmembrane transport (GO:0035435) | 6.66060195 |
| 15 | glyoxylate metabolic process (GO:0046487) | 6.58920295 |
| 16 | drug catabolic process (GO:0042737) | 6.33657427 |
| 17 | exogenous drug catabolic process (GO:0042738) | 6.18781834 |
| 18 | cysteine metabolic process (GO:0006534) | 6.06086651 |
| 19 | excretion (GO:0007588) | 6.04309513 |
| 20 | primary alcohol catabolic process (GO:0034310) | 5.81814349 |
| 21 | response to mercury ion (GO:0046689) | 5.81201512 |
| 22 | tricarboxylic acid metabolic process (GO:0072350) | 5.67193041 |
| 23 | hemidesmosome assembly (GO:0031581) | 5.40663747 |
| 24 | short-chain fatty acid metabolic process (GO:0046459) | 5.35666468 |
| 25 | homocysteine metabolic process (GO:0050667) | 5.31275568 |
| 26 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.30190271 |
| 27 | metanephric tubule development (GO:0072170) | 5.25510704 |
| 28 | metanephric nephron tubule development (GO:0072234) | 5.25510704 |
| 29 | phosphate ion homeostasis (GO:0055062) | 5.24417528 |
| 30 | trivalent inorganic anion homeostasis (GO:0072506) | 5.24417528 |
| 31 | renal absorption (GO:0070293) | 5.08684007 |
| 32 | aspartate family amino acid catabolic process (GO:0009068) | 5.03996479 |
| 33 | response to parathyroid hormone (GO:0071107) | 4.95375709 |
| 34 | amino-acid betaine transport (GO:0015838) | 4.88098341 |
| 35 | carnitine transport (GO:0015879) | 4.88098341 |
| 36 | metanephric nephron epithelium development (GO:0072243) | 4.88069995 |
| 37 | glutathione biosynthetic process (GO:0006750) | 4.80005057 |
| 38 | modified amino acid transport (GO:0072337) | 4.79591893 |
| 39 | toxin transport (GO:1901998) | 4.77436636 |
| 40 | sulfate transmembrane transport (GO:1902358) | 4.76504077 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.62435365 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 4.62435365 |
| 43 | proline metabolic process (GO:0006560) | 4.60762249 |
| 44 | protein hydroxylation (GO:0018126) | 4.53863047 |
| 45 | paraxial mesoderm development (GO:0048339) | 4.51365867 |
| 46 | metanephric epithelium development (GO:0072207) | 4.50583377 |
| 47 | plasma membrane repair (GO:0001778) | 4.40200917 |
| 48 | inner ear receptor cell development (GO:0060119) | 4.38120527 |
| 49 | branched-chain amino acid metabolic process (GO:0009081) | 4.35434295 |
| 50 | * vitamin D metabolic process (GO:0042359) | 4.34512166 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 4.21214770 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 4.20321491 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.20321491 |
| 54 | glycoside metabolic process (GO:0016137) | 4.20284263 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 4.16761043 |
| 56 | sulfur compound transport (GO:0072348) | 4.15025669 |
| 57 | membrane raft organization (GO:0031579) | 4.14887706 |
| 58 | serine family amino acid metabolic process (GO:0009069) | 4.13266117 |
| 59 | nephron tubule development (GO:0072080) | 4.12239697 |
| 60 | valine metabolic process (GO:0006573) | 4.09810846 |
| 61 | pentose-phosphate shunt (GO:0006098) | 4.05829955 |
| 62 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.05825782 |
| 63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.03457364 |
| 64 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.97815702 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.96137660 |
| 66 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.94894178 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.94055408 |
| 68 | mesodermal cell differentiation (GO:0048333) | 3.93829897 |
| 69 | peptide biosynthetic process (GO:0043043) | 3.89498893 |
| 70 | mammary gland development (GO:0030879) | 3.89378147 |
| 71 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.84658551 |
| 72 | aromatic amino acid family catabolic process (GO:0009074) | 3.83485589 |
| 73 | sulfate transport (GO:0008272) | 3.82355667 |
| 74 | progesterone metabolic process (GO:0042448) | 3.79240291 |
| 75 | lung vasculature development (GO:0060426) | 3.74929042 |
| 76 | fructose metabolic process (GO:0006000) | 3.74151641 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.71246995 |
| 78 | glutathione derivative metabolic process (GO:1901685) | 3.69817806 |
| 79 | glutathione derivative biosynthetic process (GO:1901687) | 3.69817806 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.69710753 |
| 81 | response to growth hormone (GO:0060416) | 3.66891662 |
| 82 | glutamate metabolic process (GO:0006536) | 3.66005259 |
| 83 | NADPH regeneration (GO:0006740) | 3.64844973 |
| 84 | NADH metabolic process (GO:0006734) | 3.64255011 |
| 85 | vitamin transport (GO:0051180) | 3.59877181 |
| 86 | renal tubule development (GO:0061326) | 3.59520863 |
| 87 | nuclear pore complex assembly (GO:0051292) | 3.58421912 |
| 88 | fatty acid oxidation (GO:0019395) | 3.57822938 |
| 89 | glutathione metabolic process (GO:0006749) | 3.54095084 |
| 90 | sodium-independent organic anion transport (GO:0043252) | 3.51880152 |
| 91 | indole-containing compound catabolic process (GO:0042436) | 3.51746391 |
| 92 | indolalkylamine catabolic process (GO:0046218) | 3.51746391 |
| 93 | tryptophan catabolic process (GO:0006569) | 3.51746391 |
| 94 | lipid oxidation (GO:0034440) | 3.50045153 |
| 95 | carnitine metabolic process (GO:0009437) | 3.48635587 |
| 96 | peptidyl-proline hydroxylation (GO:0019511) | 3.48286140 |
| 97 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.47664719 |
| 98 | nephron epithelium morphogenesis (GO:0072088) | 3.46209172 |
| 99 | nephron tubule morphogenesis (GO:0072078) | 3.46209172 |
| 100 | tryptophan metabolic process (GO:0006568) | 3.46052601 |
| 101 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.45671346 |
| 102 | polyol transport (GO:0015791) | 3.45663123 |
| 103 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.43824059 |
| 104 | glucose catabolic process (GO:0006007) | 3.43462770 |
| 105 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.42516833 |
| 106 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.38740011 |
| 107 | peptide catabolic process (GO:0043171) | 3.37019015 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.36582586 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.36582586 |
| 110 | desmosome organization (GO:0002934) | 3.36331987 |
| 111 | response to magnesium ion (GO:0032026) | 3.35473384 |
| 112 | branched-chain amino acid catabolic process (GO:0009083) | 3.34515134 |
| 113 | NADP metabolic process (GO:0006739) | 3.33602511 |
| 114 | histamine transport (GO:0051608) | 3.33579304 |
| 115 | nephron epithelium development (GO:0072009) | 3.32945059 |
| 116 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.31177461 |
| 117 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.28989738 |
| 118 | flavonoid metabolic process (GO:0009812) | 3.28838011 |
| 119 | sodium ion transport (GO:0006814) | 3.27550093 |
| 120 | ethanol oxidation (GO:0006069) | 3.27514337 |
| 121 | membrane protein ectodomain proteolysis (GO:0006509) | 3.27344897 |
| 122 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.27184943 |
| 123 | response to laminar fluid shear stress (GO:0034616) | 3.26882242 |
| 124 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.26849711 |
| 125 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.26849711 |
| 126 | cellular amino acid catabolic process (GO:0009063) | 3.23576050 |
| 127 | fatty acid catabolic process (GO:0009062) | 3.23335250 |
| 128 | skin morphogenesis (GO:0043589) | 3.23264967 |
| 129 | cellular ketone body metabolic process (GO:0046950) | 3.23243718 |
| 130 | positive regulation of digestive system process (GO:0060456) | 3.22199848 |
| 131 | alpha-amino acid catabolic process (GO:1901606) | 3.19313251 |
| 132 | glomerular visceral epithelial cell development (GO:0072015) | 3.18656337 |
| 133 | cobalamin metabolic process (GO:0009235) | 3.17296465 |
| 134 | notochord development (GO:0030903) | 3.16468945 |
| 135 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.15930597 |
| 136 | substrate-dependent cell migration (GO:0006929) | 3.15124088 |
| 137 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.14890365 |
| 138 | ethanol metabolic process (GO:0006067) | 3.13126061 |
| 139 | aldehyde catabolic process (GO:0046185) | 3.12912536 |
| 140 | glutamine family amino acid catabolic process (GO:0009065) | 3.12761267 |
| 141 | drug metabolic process (GO:0017144) | 3.12708977 |
| 142 | negative regulation of anoikis (GO:2000811) | 3.12026679 |
| 143 | cellular aldehyde metabolic process (GO:0006081) | 3.11653567 |
| 144 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.11628823 |
| 145 | lung epithelium development (GO:0060428) | 3.02930710 |
| 146 | epithelial cell-cell adhesion (GO:0090136) | 3.02142185 |
| 147 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.00839884 |
| 148 | C21-steroid hormone metabolic process (GO:0008207) | 2.99088466 |
| 149 | protein localization to microtubule (GO:0035372) | 2.99072838 |
| 150 | positive regulation of actin filament depolymerization (GO:0030836) | 2.97590658 |
| 151 | thrombin receptor signaling pathway (GO:0070493) | 2.95403882 |
| 152 | retinal metabolic process (GO:0042574) | 2.94551828 |
| 153 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.92417677 |
| 154 | regulation of hippo signaling (GO:0035330) | 2.91941316 |
| 155 | cell-substrate junction assembly (GO:0007044) | 2.90799279 |
| 156 | positive regulation of immune response to tumor cell (GO:0002839) | 2.89108670 |
| 157 | regulation of immune response to tumor cell (GO:0002837) | 2.89108670 |
| 158 | regulation of response to tumor cell (GO:0002834) | 2.89108670 |
| 159 | positive regulation of response to tumor cell (GO:0002836) | 2.89108670 |
| 160 | regulation of glomerular filtration (GO:0003093) | 2.84057115 |
| 161 | glucose 6-phosphate metabolic process (GO:0051156) | 2.82586088 |
| 162 | mitotic chromosome condensation (GO:0007076) | 2.81376926 |
| 163 | glomerular epithelial cell development (GO:0072310) | 2.80678747 |
| 164 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79428624 |
| 165 | regulation of mitotic spindle organization (GO:0060236) | 2.78209911 |
| 166 | nuclear pore organization (GO:0006999) | 2.77820255 |
| 167 | hepatocyte differentiation (GO:0070365) | 2.76179166 |
| 168 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.73175459 |
| 169 | stress fiber assembly (GO:0043149) | 2.72339889 |
| 170 | positive regulation of extracellular matrix organization (GO:1903055) | 2.71629170 |
| 171 | cyclooxygenase pathway (GO:0019371) | 2.71423271 |
| 172 | regulation of superoxide anion generation (GO:0032928) | 2.70697979 |
| 173 | prostaglandin metabolic process (GO:0006693) | 2.69498932 |
| 174 | prostanoid metabolic process (GO:0006692) | 2.69498932 |
| 175 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.66971540 |
| 176 | extracellular matrix assembly (GO:0085029) | 2.65572951 |
| 177 | cellular protein complex localization (GO:0034629) | 2.65509552 |
| 178 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 2.64554060 |
| 179 | glomerular basement membrane development (GO:0032836) | 2.63169802 |
| 180 | pentose metabolic process (GO:0019321) | 2.62650828 |
| 181 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.57426408 |
| 182 | pore complex assembly (GO:0046931) | 2.57378803 |
| 183 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.56998652 |
| 184 | activation of Rac GTPase activity (GO:0032863) | 2.55346805 |
| 185 | hippo signaling (GO:0035329) | 2.53782871 |
| 186 | nephron tubule formation (GO:0072079) | 2.53181829 |
| 187 | COPI coating of Golgi vesicle (GO:0048205) | 2.51045948 |
| 188 | Golgi transport vesicle coating (GO:0048200) | 2.51045948 |
| 189 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.47239739 |
| 190 | regulation of keratinocyte differentiation (GO:0045616) | 2.45529786 |
| 191 | endothelial cell morphogenesis (GO:0001886) | 2.45095665 |
| 192 | polyketide metabolic process (GO:0030638) | 10.2667246 |
| 193 | doxorubicin metabolic process (GO:0044598) | 10.2667246 |
| 194 | daunorubicin metabolic process (GO:0044597) | 10.2667246 |
| 195 | drug transmembrane transport (GO:0006855) | 10.0478118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.41141694 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.21942229 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.54997303 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.33128803 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.20577740 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.18625824 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.09273926 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.45566244 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.41512052 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.36458268 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.26286379 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20041315 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.10233849 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.96014537 |
| 15 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.76622812 |
| 16 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.76622812 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.63912858 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.55437932 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.50775757 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46705462 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.37016258 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19915956 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15393255 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.13393138 |
| 25 | ATF3_27146783_Chip-Seq_COLON_Human | 2.07988405 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.06210540 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06164163 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05078791 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97638691 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.97300359 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.95510726 |
| 32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.94294329 |
| 33 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.92326617 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88630317 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86729486 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.85880413 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.84200440 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.82999610 |
| 39 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.82778166 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.78891436 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.74149286 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72307696 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69753905 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68287907 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.64925679 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64496083 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64442222 |
| 48 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.64081546 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.63187454 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55392177 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54819782 |
| 52 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54008285 |
| 53 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.50922055 |
| 54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.49842625 |
| 55 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.46614595 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45986464 |
| 57 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44611249 |
| 58 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.40167300 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38579996 |
| 60 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38314729 |
| 61 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36560536 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36057027 |
| 63 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.35548427 |
| 64 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.33375933 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32858520 |
| 66 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.31392792 |
| 67 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28226969 |
| 68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27980582 |
| 69 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.27711385 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25866508 |
| 71 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.25787423 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25340160 |
| 73 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24622108 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23490175 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22067029 |
| 76 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21008154 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20524511 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19865061 |
| 79 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.19152988 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19102551 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17844279 |
| 82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17501769 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17100353 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16699071 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14721063 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14640763 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13581674 |
| 88 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11983783 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11607084 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09471259 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.09002462 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07963908 |
| 93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07906875 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07858806 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06157826 |
| 96 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05648668 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04947457 |
| 98 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.04265769 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04039480 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03528254 |
| 101 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03369052 |
| 102 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02832487 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02172674 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01513895 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01373035 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01328323 |
| 107 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99548136 |
| 108 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.99246776 |
| 109 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.96404302 |
| 110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95817246 |
| 111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95369659 |
| 112 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94971506 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94411462 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94317611 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92342100 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92267216 |
| 117 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.91134502 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91070902 |
| 119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90347944 |
| 120 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90270228 |
| 121 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89769816 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89672056 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88171853 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88060520 |
| 125 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88032533 |
| 126 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.87768460 |
| 127 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87426415 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86413994 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86413994 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85770768 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84928120 |
| 132 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.84028655 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82965642 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82865089 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82851743 |
| 136 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82732046 |
| 137 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81779477 |
| 138 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81159785 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79989657 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79704713 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79469081 |
| 142 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79446264 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76414471 |
| 144 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74805422 |
| 145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.73488927 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.72018029 |
| 147 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71987687 |
| 148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71767249 |
| 149 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71767249 |
| 150 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.71159201 |
| 151 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70750179 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70184057 |
| 153 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69916988 |
| 154 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69508109 |
| 155 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.69284463 |
| 156 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69218591 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.69128104 |
| 158 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.69021116 |
| 159 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69004459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.25663553 |
| 2 | MP0004043_abnormal_pH_regulation | 6.11156197 |
| 3 | MP0003195_calcinosis | 4.85317161 |
| 4 | * MP0004019_abnormal_vitamin_homeostasis | 4.64265092 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 4.59619883 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 4.54438440 |
| 7 | MP0005332_abnormal_amino_acid | 4.46110164 |
| 8 | MP0002736_abnormal_nociception_after | 4.30336979 |
| 9 | * MP0009643_abnormal_urine_homeostasis | 3.90842084 |
| 10 | * MP0001765_abnormal_ion_homeostasis | 3.72760041 |
| 11 | MP0003950_abnormal_plasma_membrane | 3.60944769 |
| 12 | MP0005248_abnormal_Harderian_gland | 3.58776500 |
| 13 | MP0005365_abnormal_bile_salt | 3.25276965 |
| 14 | MP0001756_abnormal_urination | 3.23833241 |
| 15 | * MP0005636_abnormal_mineral_homeostasis | 3.13436836 |
| 16 | * MP0002136_abnormal_kidney_physiology | 3.00211869 |
| 17 | MP0003252_abnormal_bile_duct | 2.93434714 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.92606235 |
| 19 | MP0005076_abnormal_cell_differentiation | 2.89229076 |
| 20 | MP0004858_abnormal_nervous_system | 2.88274997 |
| 21 | MP0001958_emphysema | 2.68409224 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.51295426 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36874749 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.36810383 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.29169118 |
| 26 | MP0005377_hearing/vestibular/ear_phenot | 2.24760467 |
| 27 | MP0003878_abnormal_ear_physiology | 2.24760467 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.22290635 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 2.16311689 |
| 30 | MP0001849_ear_inflammation | 2.10582386 |
| 31 | MP0000579_abnormal_nail_morphology | 2.08449190 |
| 32 | MP0001348_abnormal_lacrimal_gland | 2.07367536 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 2.01853349 |
| 34 | MP0005623_abnormal_meninges_morphology | 1.98535825 |
| 35 | MP0003091_abnormal_cell_migration | 1.97806507 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.83680999 |
| 37 | MP0000383_abnormal_hair_follicle | 1.82685652 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.81729619 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.80479870 |
| 40 | MP0002928_abnormal_bile_duct | 1.80007349 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.76704156 |
| 42 | MP0005409_darkened_coat_color | 1.67837020 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63320579 |
| 44 | MP0010678_abnormal_skin_adnexa | 1.62039248 |
| 45 | MP0005023_abnormal_wound_healing | 1.58102661 |
| 46 | MP0005451_abnormal_body_composition | 1.57595689 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.57242771 |
| 48 | MP0003186_abnormal_redox_activity | 1.55639429 |
| 49 | MP0002168_other_aberrant_phenotype | 1.53253834 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.51344517 |
| 51 | MP0000627_abnormal_mammary_gland | 1.49931025 |
| 52 | MP0004885_abnormal_endolymph | 1.48689844 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.48681798 |
| 54 | MP0009053_abnormal_anal_canal | 1.44452470 |
| 55 | MP0010771_integument_phenotype | 1.42510567 |
| 56 | MP0008932_abnormal_embryonic_tissue | 1.35894936 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.30570294 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.27713126 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 1.26619023 |
| 60 | MP0002896_abnormal_bone_mineralization | 1.23877477 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.19511194 |
| 62 | MP0000230_abnormal_systemic_arterial | 1.19139199 |
| 63 | MP0002233_abnormal_nose_morphology | 1.16578031 |
| 64 | MP0004233_abnormal_muscle_weight | 1.15869602 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.15336907 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.14860720 |
| 67 | MP0004484_altered_response_of | 1.12834190 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.07974872 |
| 69 | MP0000467_abnormal_esophagus_morphology | 1.06693471 |
| 70 | MP0002060_abnormal_skin_morphology | 1.06330325 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.04811613 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.04264224 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.03552924 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.03422565 |
| 75 | MP0000733_abnormal_muscle_development | 1.01701144 |
| 76 | MP0006138_congestive_heart_failure | 1.00535298 |
| 77 | * MP0002135_abnormal_kidney_morphology | 0.98870328 |
| 78 | MP0001661_extended_life_span | 0.98029062 |
| 79 | MP0005670_abnormal_white_adipose | 0.97346296 |
| 80 | MP0003283_abnormal_digestive_organ | 0.96702096 |
| 81 | MP0004147_increased_porphyrin_level | 0.96394045 |
| 82 | MP0002006_tumorigenesis | 0.96292794 |
| 83 | MP0000858_altered_metastatic_potential | 0.96243683 |
| 84 | MP0003941_abnormal_skin_development | 0.96190823 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.94184154 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 0.94154702 |
| 87 | MP0001873_stomach_inflammation | 0.93279724 |
| 88 | MP0002822_catalepsy | 0.91758454 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.91640633 |
| 90 | MP0002796_impaired_skin_barrier | 0.91197407 |
| 91 | MP0005165_increased_susceptibility_to | 0.88400203 |
| 92 | MP0005193_abnormal_anterior_eye | 0.88221843 |
| 93 | MP0001730_embryonic_growth_arrest | 0.88033081 |
| 94 | MP0002697_abnormal_eye_size | 0.87240187 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.86720331 |
| 96 | MP0000350_abnormal_cell_proliferation | 0.85776730 |
| 97 | MP0001666_abnormal_nutrient_absorption | 0.85000821 |
| 98 | MP0001485_abnormal_pinna_reflex | 0.84637673 |
| 99 | MP0000490_abnormal_crypts_of | 0.83290184 |
| 100 | MP0005621_abnormal_cell_physiology | 0.82416935 |
| 101 | MP0002086_abnormal_extraembryonic_tissu | 0.82070289 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.81378775 |
| 103 | MP0005501_abnormal_skin_physiology | 0.80162649 |
| 104 | MP0003755_abnormal_palate_morphology | 0.80126710 |
| 105 | MP0003111_abnormal_nucleus_morphology | 0.79252586 |
| 106 | MP0009764_decreased_sensitivity_to | 0.79035336 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.78653413 |
| 108 | MP0004197_abnormal_fetal_growth/weight/ | 0.78152451 |
| 109 | MP0005535_abnormal_body_temperature | 0.78091100 |
| 110 | MP0005395_other_phenotype | 0.77679059 |
| 111 | MP0002089_abnormal_postnatal_growth/wei | 0.76646281 |
| 112 | MP0003077_abnormal_cell_cycle | 0.75940019 |
| 113 | MP0005164_abnormal_response_to | 0.75638686 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.75623692 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.74895128 |
| 116 | MP0001340_abnormal_eyelid_morphology | 0.74079148 |
| 117 | MP0001881_abnormal_mammary_gland | 0.73658723 |
| 118 | MP0002092_abnormal_eye_morphology | 0.72223151 |
| 119 | MP0002084_abnormal_developmental_patter | 0.72220574 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.71525346 |
| 121 | MP0003984_embryonic_growth_retardation | 0.71331722 |
| 122 | MP0001286_abnormal_eye_development | 0.70690640 |
| 123 | MP0004272_abnormal_basement_membrane | 0.70209961 |
| 124 | MP0000534_abnormal_ureter_morphology | 0.70142993 |
| 125 | MP0010307_abnormal_tumor_latency | 0.69605208 |
| 126 | MP0001764_abnormal_homeostasis | 0.68413368 |
| 127 | MP0001915_intracranial_hemorrhage | 0.67484178 |
| 128 | MP0003935_abnormal_craniofacial_develop | 0.66884391 |
| 129 | MP0001672_abnormal_embryogenesis/_devel | 0.66409691 |
| 130 | MP0005380_embryogenesis_phenotype | 0.66409691 |
| 131 | MP0000428_abnormal_craniofacial_morphol | 0.65762678 |
| 132 | * MP0009642_abnormal_blood_homeostasis | 0.65323805 |
| 133 | MP0001697_abnormal_embryo_size | 0.64518670 |
| 134 | MP0002734_abnormal_mechanical_nocicepti | 0.64221954 |
| 135 | MP0002088_abnormal_embryonic_growth/wei | 0.63465252 |
| 136 | MP0003936_abnormal_reproductive_system | 0.63369634 |
| 137 | MP0008438_abnormal_cutaneous_collagen | 0.62377116 |
| 138 | MP0001663_abnormal_digestive_system | 0.62351449 |
| 139 | MP0002177_abnormal_outer_ear | 0.61956871 |
| 140 | MP0002098_abnormal_vibrissa_morphology | 0.61932170 |
| 141 | MP0003868_abnormal_feces_composition | 0.60092096 |
| 142 | MP0000747_muscle_weakness | 0.57309774 |
| 143 | MP0000609_abnormal_liver_physiology | 0.51586270 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.51046269 |
| 145 | MP0002115_abnormal_skeleton_extremities | 0.50578091 |
| 146 | MP0009278_abnormal_bone_marrow | 0.50396086 |
| 147 | MP0003315_abnormal_perineum_morphology | 0.49110057 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.48994456 |
| 149 | MP0003045_fibrosis | 0.48547959 |
| 150 | MP0008004_abnormal_stomach_pH | 0.48077647 |
| 151 | MP0005166_decreased_susceptibility_to | 0.46132110 |
| 152 | MP0005381_digestive/alimentary_phenotyp | 0.46018147 |
| 153 | MP0000598_abnormal_liver_morphology | 0.45709108 |
| 154 | MP0002998_abnormal_bone_remodeling | 0.45320688 |
| 155 | MP0001664_abnormal_digestion | 0.43644891 |
| 156 | MP0005595_abnormal_vascular_smooth | 0.43543921 |
| 157 | MP0010329_abnormal_lipoprotein_level | 0.43228083 |
| 158 | MP0004742_abnormal_vestibular_system | 0.43084707 |
| 159 | MP0003959_abnormal_lean_body | 0.42941470 |
| 160 | MP0003879_abnormal_hair_cell | 0.42896028 |
| 161 | MP0003795_abnormal_bone_structure | 0.42229768 |
| 162 | MP0003953_abnormal_hormone_level | 0.40750189 |
| 163 | MP0005408_hypopigmentation | 0.40732154 |
| 164 | MP0000762_abnormal_tongue_morphology | 0.40675623 |
| 165 | MP0000163_abnormal_cartilage_morphology | 0.39897137 |
| 166 | MP0001177_atelectasis | 0.38051132 |
| 167 | MP0008469_abnormal_protein_level | 0.37920104 |
| 168 | MP0005620_abnormal_muscle_contractility | 0.36873379 |
| 169 | MP0003172_abnormal_lysosome_physiology | 0.36298336 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.35584388 |
| 171 | MP0003221_abnormal_cardiomyocyte_apopto | 0.35498689 |
| 172 | MP0009780_abnormal_chondrocyte_physiolo | 0.34353626 |
| 173 | MP0002735_abnormal_chemical_nociception | 0.33521562 |
| 174 | MP0005167_abnormal_blood-brain_barrier | 0.32939295 |
| 175 | MP0000377_abnormal_hair_follicle | 0.32711730 |
| 176 | MP0000678_abnormal_parathyroid_gland | 0.31818135 |
| 177 | MP0002972_abnormal_cardiac_muscle | 0.30708138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.81730360 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.22684689 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.20738490 |
| 4 | Gout (HP:0001997) | 7.10312740 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.73475750 |
| 6 | Hypomagnesemia (HP:0002917) | 6.41040206 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 6.29467586 |
| 8 | * Polyuria (HP:0000103) | 6.14108510 |
| 9 | * Abnormal urine output (HP:0012590) | 5.68508492 |
| 10 | * Abnormality of renal excretion (HP:0011036) | 5.51713705 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.45791684 |
| 12 | Proximal tubulopathy (HP:0000114) | 5.43099066 |
| 13 | Polydipsia (HP:0001959) | 5.23097523 |
| 14 | Abnormal drinking behavior (HP:0030082) | 5.23097523 |
| 15 | Hyperuricemia (HP:0002149) | 5.04478313 |
| 16 | Increased purine levels (HP:0004368) | 5.04478313 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 4.86329549 |
| 18 | Alkalosis (HP:0001948) | 4.84557228 |
| 19 | Tetany (HP:0001281) | 4.82684306 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.77499519 |
| 21 | Selective tooth agenesis (HP:0001592) | 4.75140617 |
| 22 | Abnormality of purine metabolism (HP:0004352) | 4.57354002 |
| 23 | Bronchomalacia (HP:0002780) | 4.47049602 |
| 24 | Renal salt wasting (HP:0000127) | 4.43507848 |
| 25 | Hyperaldosteronism (HP:0000859) | 4.36738499 |
| 26 | Hyperglycinuria (HP:0003108) | 4.16949225 |
| 27 | Broad face (HP:0000283) | 4.08314660 |
| 28 | Arterial tortuosity (HP:0005116) | 3.97902690 |
| 29 | * Hypercalciuria (HP:0002150) | 3.89510956 |
| 30 | Abnormality of urine glucose concentration (HP:0011016) | 3.85819271 |
| 31 | Glycosuria (HP:0003076) | 3.85819271 |
| 32 | Generalized aminoaciduria (HP:0002909) | 3.84829012 |
| 33 | Hypokalemia (HP:0002900) | 3.61465750 |
| 34 | Renal tubular acidosis (HP:0001947) | 3.57974967 |
| 35 | Sex reversal (HP:0012245) | 3.53578707 |
| 36 | Abnormal sex determination (HP:0012244) | 3.53578707 |
| 37 | Atrophic scars (HP:0001075) | 3.47684032 |
| 38 | Abnormality of oral frenula (HP:0000190) | 3.46835983 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.41989511 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.41989511 |
| 41 | Protrusio acetabuli (HP:0003179) | 3.40600325 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.37621140 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.36596308 |
| 44 | Vascular tortuosity (HP:0004948) | 3.33209025 |
| 45 | Unilateral renal agenesis (HP:0000122) | 3.32895771 |
| 46 | Delayed epiphyseal ossification (HP:0002663) | 3.30364387 |
| 47 | Ankyloglossia (HP:0010296) | 3.28168484 |
| 48 | Hyperacusis (HP:0010780) | 3.27759398 |
| 49 | Hyperphosphaturia (HP:0003109) | 3.27353105 |
| 50 | Milia (HP:0001056) | 3.18207587 |
| 51 | Vertebral arch anomaly (HP:0008438) | 3.16279251 |
| 52 | Abnormal urine phosphate concentration (HP:0012599) | 3.16247568 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 3.14339736 |
| 54 | Hydroxyprolinuria (HP:0003080) | 3.14339736 |
| 55 | Ketoacidosis (HP:0001993) | 3.13678489 |
| 56 | Missing ribs (HP:0000921) | 3.13651490 |
| 57 | Focal segmental glomerulosclerosis (HP:0000097) | 3.12423654 |
| 58 | Abnormality of the nasal septum (HP:0000419) | 3.10992659 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.05007000 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 3.05007000 |
| 61 | Fragile skin (HP:0001030) | 3.04759808 |
| 62 | Abnormality of potassium homeostasis (HP:0011042) | 3.04521747 |
| 63 | 11 pairs of ribs (HP:0000878) | 3.04503722 |
| 64 | Glossoptosis (HP:0000162) | 2.97095507 |
| 65 | Vascular calcification (HP:0004934) | 2.89523548 |
| 66 | Broad metatarsal (HP:0001783) | 2.86196514 |
| 67 | Shallow orbits (HP:0000586) | 2.84038906 |
| 68 | Hypophosphatemia (HP:0002148) | 2.78952599 |
| 69 | Ketosis (HP:0001946) | 2.74008701 |
| 70 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72418429 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.70883514 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.68982330 |
| 73 | * Nephrolithiasis (HP:0000787) | 2.68855481 |
| 74 | Turricephaly (HP:0000262) | 2.67738947 |
| 75 | Rickets (HP:0002748) | 2.66818260 |
| 76 | * Nephrocalcinosis (HP:0000121) | 2.65150433 |
| 77 | Abnormality of the gastric mucosa (HP:0004295) | 2.64938482 |
| 78 | Flat acetabular roof (HP:0003180) | 2.64770295 |
| 79 | Hypoplastic scapulae (HP:0000882) | 2.64339761 |
| 80 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.64339761 |
| 81 | Metaphyseal cupping (HP:0003021) | 2.60797344 |
| 82 | Cone-rod dystrophy (HP:0000548) | 2.56996243 |
| 83 | Insomnia (HP:0100785) | 2.55602992 |
| 84 | Ankle contracture (HP:0006466) | 2.54348786 |
| 85 | Nail dystrophy (HP:0008404) | 2.49860829 |
| 86 | Wormian bones (HP:0002645) | 2.47348935 |
| 87 | Hyperglycinemia (HP:0002154) | 2.47271213 |
| 88 | Thin bony cortex (HP:0002753) | 2.45971059 |
| 89 | * Dehydration (HP:0001944) | 2.45343571 |
| 90 | Hyperammonemia (HP:0001987) | 2.45062980 |
| 91 | Ulnar bowing (HP:0003031) | 2.43615315 |
| 92 | Confusion (HP:0001289) | 2.42896211 |
| 93 | Deviation of the thumb (HP:0009603) | 2.41309640 |
| 94 | Tibial bowing (HP:0002982) | 2.40255337 |
| 95 | Abnormal ossification of hand bones (HP:0005921) | 2.38875052 |
| 96 | Lymphangioma (HP:0100764) | 2.35286513 |
| 97 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34661003 |
| 98 | Malnutrition (HP:0004395) | 2.33745107 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.33251826 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.30143777 |
| 101 | Abnormal number of incisors (HP:0011064) | 2.29504896 |
| 102 | Small epiphyses (HP:0010585) | 2.29365470 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 2.28322589 |
| 104 | Tubular atrophy (HP:0000092) | 2.26869463 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.25645270 |
| 106 | Widely patent fontanelles and sutures (HP:0004492) | 2.24809104 |
| 107 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.24608784 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24379820 |
| 109 | Abnormality of sodium homeostasis (HP:0010931) | 2.22950457 |
| 110 | Glucose intolerance (HP:0000833) | 2.22778470 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.21224459 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21224459 |
| 113 | Ureteral stenosis (HP:0000071) | 2.20336378 |
| 114 | Renal tubular dysfunction (HP:0000124) | 2.19952211 |
| 115 | Abnormality of renal resorption (HP:0011038) | 2.19058125 |
| 116 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.18624086 |
| 117 | Hyponatremia (HP:0002902) | 2.14301345 |
| 118 | Squamous cell carcinoma (HP:0002860) | 2.13113081 |
| 119 | Enlarged kidneys (HP:0000105) | 2.11972330 |
| 120 | Rhizomelia (HP:0008905) | 2.11886078 |
| 121 | Wide nose (HP:0000445) | 2.11591522 |
| 122 | Hypoplasia of the uterus (HP:0000013) | 2.11551029 |
| 123 | Pterygium (HP:0001059) | 2.10782567 |
| 124 | Short nail (HP:0001799) | 2.10417690 |
| 125 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.09982030 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 2.09700992 |
| 127 | Adrenal overactivity (HP:0002717) | 2.09554713 |
| 128 | Coronal craniosynostosis (HP:0004440) | 2.09420440 |
| 129 | Fibular hypoplasia (HP:0003038) | 2.09390824 |
| 130 | Potter facies (HP:0002009) | 2.08647116 |
| 131 | Facial shape deformation (HP:0011334) | 2.08647116 |
| 132 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.08412853 |
| 133 | Tubulointerstitial fibrosis (HP:0005576) | 2.06597370 |
| 134 | Poikiloderma (HP:0001029) | 2.06588068 |
| 135 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.06409867 |
| 136 | Ureteral obstruction (HP:0006000) | 2.05746306 |
| 137 | Plantar hyperkeratosis (HP:0007556) | 2.05484130 |
| 138 | Short humerus (HP:0005792) | 2.05180956 |
| 139 | Prolonged neonatal jaundice (HP:0006579) | 2.04569852 |
| 140 | Broad palm (HP:0001169) | 2.04397344 |
| 141 | Corneal erosion (HP:0200020) | 2.02179985 |
| 142 | Abnormal pancreas size (HP:0012094) | 2.01573319 |
| 143 | Vertebral compression fractures (HP:0002953) | 2.01421333 |
| 144 | * Vomiting (HP:0002013) | 2.01412036 |
| 145 | Abnormal tarsal ossification (HP:0008369) | 2.00199689 |
| 146 | Alopecia of scalp (HP:0002293) | 2.00094069 |
| 147 | Enlarged penis (HP:0000040) | 1.99877685 |
| 148 | Onycholysis (HP:0001806) | 1.98385906 |
| 149 | Proximal placement of thumb (HP:0009623) | 1.98186562 |
| 150 | Trismus (HP:0000211) | 1.97855919 |
| 151 | Premature rupture of membranes (HP:0001788) | 1.97684548 |
| 152 | Trigonocephaly (HP:0000243) | 1.96986207 |
| 153 | Right ventricular cardiomyopathy (HP:0011663) | 1.96599508 |
| 154 | Abnormality of carpal bone ossification (HP:0006257) | 1.96542036 |
| 155 | Metabolic acidosis (HP:0001942) | 1.96413087 |
| 156 | Methylmalonic aciduria (HP:0012120) | 1.95432203 |
| 157 | Fibular aplasia (HP:0002990) | 1.94329901 |
| 158 | Ridged nail (HP:0001807) | 1.93737981 |
| 159 | Orthostatic hypotension (HP:0001278) | 1.93651532 |
| 160 | Chondrocalcinosis (HP:0000934) | 1.92469738 |
| 161 | Hypoplasia of dental enamel (HP:0006297) | 1.91642522 |
| 162 | Chorioretinal atrophy (HP:0000533) | 1.91433304 |
| 163 | Decreased circulating renin level (HP:0003351) | 1.91095255 |
| 164 | Hypercholesterolemia (HP:0003124) | 1.88709401 |
| 165 | Humeroradial synostosis (HP:0003041) | 1.87976634 |
| 166 | Synostosis involving the elbow (HP:0003938) | 1.87976634 |
| 167 | Hypophosphatemic rickets (HP:0004912) | 1.87392697 |
| 168 | Bicornuate uterus (HP:0000813) | 1.86919091 |
| 169 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.86778981 |
| 170 | Midface retrusion (HP:0011800) | 1.86522994 |
| 171 | Thick nail (HP:0001805) | 1.85819435 |
| 172 | Multiple enchondromatosis (HP:0005701) | 1.85558121 |
| 173 | Cervical subluxation (HP:0003308) | 1.85513026 |
| 174 | Glomerulosclerosis (HP:0000096) | 1.83903877 |
| 175 | Abnormality of the acetabulum (HP:0003170) | 1.83283233 |
| 176 | Arnold-Chiari malformation (HP:0002308) | 1.82210299 |
| 177 | Abnormality of Sharpey fibers (HP:0100685) | 1.82066825 |
| 178 | Micronodular cirrhosis (HP:0001413) | 1.81783436 |
| 179 | * Elfin facies (HP:0004428) | 1.81324245 |
| 180 | Bowed forearm bones (HP:0003956) | 1.81147626 |
| 181 | Bowing of the arm (HP:0006488) | 1.81147626 |
| 182 | Limited elbow extension (HP:0001377) | 1.79818581 |
| 183 | Vertebral hypoplasia (HP:0008417) | 1.79260821 |
| 184 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.79260821 |
| 185 | Sensorimotor neuropathy (HP:0007141) | 1.78895043 |
| 186 | Axonal loss (HP:0003447) | 1.77975940 |
| 187 | Abnormality of the costochondral junction (HP:0000919) | 1.77936617 |
| 188 | Elevated alkaline phosphatase (HP:0003155) | 1.77473456 |
| 189 | Blepharitis (HP:0000498) | 1.76969253 |
| 190 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.76852525 |
| 191 | * Lethargy (HP:0001254) | 1.76370189 |
| 192 | Nausea (HP:0002018) | 1.73375693 |
| 193 | Metaphyseal irregularity (HP:0003025) | 1.72981096 |
| 194 | Enlarged epiphyses (HP:0010580) | 1.70592989 |
| 195 | Metaphyseal dysplasia (HP:0100255) | 1.68639292 |
| 196 | Abnormality of serum amino acid levels (HP:0003112) | 1.64813598 |
| 197 | Persistence of primary teeth (HP:0006335) | 1.63819020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.95342108 |
| 2 | OXSR1 | 7.05417812 |
| 3 | WNK3 | 6.26883159 |
| 4 | STK39 | 4.99368805 |
| 5 | TTN | 3.17172422 |
| 6 | MST4 | 2.73407915 |
| 7 | STK38L | 2.70467580 |
| 8 | CDK12 | 2.35740460 |
| 9 | BCKDK | 2.07141503 |
| 10 | PBK | 1.94286680 |
| 11 | LMTK2 | 1.90630364 |
| 12 | PIK3CG | 1.89348569 |
| 13 | PDK3 | 1.88640218 |
| 14 | PDK4 | 1.88640218 |
| 15 | EIF2AK1 | 1.84688215 |
| 16 | FRK | 1.80352012 |
| 17 | WNK1 | 1.77113080 |
| 18 | SGK223 | 1.60303540 |
| 19 | SGK494 | 1.60303540 |
| 20 | CDK8 | 1.56827848 |
| 21 | STK38 | 1.56324027 |
| 22 | NEK1 | 1.54458718 |
| 23 | RIPK1 | 1.47331067 |
| 24 | MST1R | 1.45680023 |
| 25 | MAP3K9 | 1.31697119 |
| 26 | TRPM7 | 1.25860037 |
| 27 | FLT3 | 1.24113115 |
| 28 | TAOK3 | 1.20604959 |
| 29 | PDK2 | 1.19824018 |
| 30 | MAP3K7 | 1.13232243 |
| 31 | RPS6KB2 | 1.02832486 |
| 32 | TESK1 | 1.01289697 |
| 33 | EPHB1 | 0.99729393 |
| 34 | GSK3A | 0.92269766 |
| 35 | MELK | 0.92201512 |
| 36 | LIMK1 | 0.88431875 |
| 37 | LRRK2 | 0.88346098 |
| 38 | ERBB3 | 0.88325142 |
| 39 | SGK3 | 0.84965327 |
| 40 | FER | 0.83505872 |
| 41 | BRSK1 | 0.82600535 |
| 42 | LATS1 | 0.81802201 |
| 43 | FGFR4 | 0.80270455 |
| 44 | BRSK2 | 0.79000091 |
| 45 | PTK6 | 0.74117578 |
| 46 | MAP3K3 | 0.73365782 |
| 47 | PTK2 | 0.73153423 |
| 48 | EPHA3 | 0.71386477 |
| 49 | ERBB4 | 0.68656063 |
| 50 | EEF2K | 0.67266917 |
| 51 | JAK3 | 0.66831511 |
| 52 | MAP3K2 | 0.66264378 |
| 53 | TSSK6 | 0.66081988 |
| 54 | FGR | 0.65040094 |
| 55 | PAK3 | 0.63895866 |
| 56 | CDK9 | 0.63556516 |
| 57 | ABL2 | 0.63037853 |
| 58 | GRK6 | 0.62424021 |
| 59 | NTRK1 | 0.61917934 |
| 60 | SGK1 | 0.61502117 |
| 61 | AURKB | 0.59821780 |
| 62 | TGFBR2 | 0.59401179 |
| 63 | DYRK1B | 0.57829974 |
| 64 | SGK2 | 0.56996373 |
| 65 | EIF2AK3 | 0.55295921 |
| 66 | PIK3CA | 0.53563553 |
| 67 | CAMK2B | 0.53208456 |
| 68 | ICK | 0.52883255 |
| 69 | PIM2 | 0.52258185 |
| 70 | TTK | 0.50734296 |
| 71 | JAK1 | 0.50536244 |
| 72 | ALK | 0.49831254 |
| 73 | EIF2AK2 | 0.49071233 |
| 74 | ERN1 | 0.48862768 |
| 75 | STK11 | 0.46103289 |
| 76 | MET | 0.45474689 |
| 77 | CAMK2G | 0.45436355 |
| 78 | CSF1R | 0.44616466 |
| 79 | PRPF4B | 0.43497921 |
| 80 | EPHA2 | 0.42625819 |
| 81 | SCYL2 | 0.42329830 |
| 82 | STK10 | 0.42159223 |
| 83 | PAK4 | 0.42088171 |
| 84 | PRKCE | 0.41996754 |
| 85 | EPHB2 | 0.40591292 |
| 86 | ARAF | 0.39599645 |
| 87 | BCR | 0.38488110 |
| 88 | PRKAA1 | 0.38485299 |
| 89 | MAPK11 | 0.37784418 |
| 90 | NEK2 | 0.37539896 |
| 91 | NEK6 | 0.37452232 |
| 92 | CDK4 | 0.36396876 |
| 93 | PRKD3 | 0.36371942 |
| 94 | DDR2 | 0.36007252 |
| 95 | IRAK1 | 0.35949540 |
| 96 | PRKG2 | 0.35603745 |
| 97 | SIK1 | 0.35487054 |
| 98 | AURKA | 0.35211142 |
| 99 | IRAK3 | 0.34856924 |
| 100 | BRD4 | 0.34526041 |
| 101 | CHUK | 0.33671599 |
| 102 | BUB1 | 0.32964115 |
| 103 | CDK7 | 0.32462170 |
| 104 | NEK9 | 0.31355987 |
| 105 | IGF1R | 0.29724951 |
| 106 | PRKAA2 | 0.29579201 |
| 107 | CAMK2D | 0.29317210 |
| 108 | PLK1 | 0.28364164 |
| 109 | PDPK1 | 0.28008479 |
| 110 | INSRR | 0.27419474 |
| 111 | FGFR3 | 0.26564506 |
| 112 | PRKCZ | 0.26385554 |
| 113 | STK4 | 0.26263459 |
| 114 | KSR1 | 0.26251617 |
| 115 | PDGFRA | 0.25746397 |
| 116 | MAP3K14 | 0.25649846 |
| 117 | AKT2 | 0.25370661 |
| 118 | SMG1 | 0.25205000 |
| 119 | IRAK2 | 0.24346593 |
| 120 | PRKCI | 0.23254869 |
| 121 | MAPKAPK3 | 0.23209032 |
| 122 | FGFR2 | 0.22909619 |
| 123 | PINK1 | 0.22123550 |
| 124 | PAK2 | 0.22043716 |
| 125 | BMPR2 | 0.21800918 |
| 126 | TIE1 | 0.20448297 |
| 127 | ROCK1 | 0.19299880 |
| 128 | PRKD2 | 0.19260880 |
| 129 | STK3 | 0.19248569 |
| 130 | BMX | 0.19071398 |
| 131 | LATS2 | 0.18239776 |
| 132 | MAP3K8 | 0.14778713 |
| 133 | PDK1 | 0.14651148 |
| 134 | PRKCA | 0.13597371 |
| 135 | TRIB3 | 0.13485919 |
| 136 | PRKACG | 0.11783880 |
| 137 | ABL1 | 0.10687026 |
| 138 | CSNK1E | 0.10505404 |
| 139 | INSR | 0.10192400 |
| 140 | MYLK | 0.10063019 |
| 141 | SRC | 0.09341220 |
| 142 | PRKCD | 0.09205079 |
| 143 | PRKACA | 0.08926176 |
| 144 | PTK2B | 0.06722827 |
| 145 | NME2 | 0.06396402 |
| 146 | PRKCQ | 0.05690002 |
| 147 | CDK6 | 0.05417054 |
| 148 | ZAK | 0.04994150 |
| 149 | ERBB2 | 0.04483431 |
| 150 | PDGFRB | 0.04116793 |
| 151 | CAMK1G | 0.04077264 |
| 152 | FGFR1 | 0.03934144 |
| 153 | MTOR | 0.03862628 |
| 154 | CAMK4 | 0.03404644 |
| 155 | EGFR | 0.03237915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.94730862 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.51394672 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.23023242 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.12650561 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.09937873 |
| 6 | Adherens junction_Homo sapiens_hsa04520 | 3.05002587 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.93818116 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.92337180 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.90804328 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.78827274 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.65942802 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51059600 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.49612971 |
| 14 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.47915227 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.46091972 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.37896669 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26355436 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.25808556 |
| 19 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.23981861 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.22009022 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.18658773 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.16714245 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 2.10285199 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.01868818 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99478295 |
| 26 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.96220334 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94711720 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86075752 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83368127 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.83352707 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.83166719 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79471349 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.74517064 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69639145 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.65487416 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.65294245 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62293254 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57700358 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57461276 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46883187 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.44401723 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44067827 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42554984 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.42107211 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38282057 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31891080 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29576117 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.28670563 |
| 49 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.28375209 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.27712574 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27046194 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.26018472 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23867430 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.23317499 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22863893 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21102799 |
| 57 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.21020535 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13997319 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13065615 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12438841 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 1.12159466 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 1.12136739 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10918927 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09627950 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07370996 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 1.06195728 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05244543 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 1.02596168 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01531516 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00295329 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98192352 |
| 72 | Pathways in cancer_Homo sapiens_hsa05200 | 0.95717499 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.95304792 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94357507 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91533640 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91045554 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89672937 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86787735 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86122769 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.85463948 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85294796 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83689807 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82855036 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82113054 |
| 85 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.81325231 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79604544 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79080628 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79063429 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78435336 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.77775900 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75733248 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74852543 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.74461894 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74437032 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71912823 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70081915 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66557021 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66530915 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66365777 |
| 100 | Mismatch repair_Homo sapiens_hsa03430 | 0.66224602 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66074657 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65431219 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64894915 |
| 104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64074698 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.63468132 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.62256378 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61751833 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.61662285 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59199950 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58917067 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57903835 |
| 112 | Axon guidance_Homo sapiens_hsa04360 | 0.57582709 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57444344 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56844713 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.54603108 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54463853 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53529516 |
| 118 | Base excision repair_Homo sapiens_hsa03410 | 0.53251752 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52686372 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51218291 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50521683 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47929391 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46664987 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.46367432 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45988831 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45516548 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.43962403 |
| 128 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43741722 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43483535 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.43202324 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43143445 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42990186 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41723597 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.40657210 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32442188 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29940145 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29611784 |
| 138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28378393 |
| 139 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23513866 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23038225 |
| 141 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22169966 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21762055 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.20319647 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19901732 |
| 145 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19894038 |
| 146 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17989822 |
| 147 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17748427 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16211202 |
| 149 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15957423 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15853988 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.13433171 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13037242 |
| 153 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11324548 |
| 154 | Bladder cancer_Homo sapiens_hsa05219 | 0.10708874 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10671184 |
| 156 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10596109 |
| 157 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09509281 |
| 158 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.07902965 |
| 159 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07759944 |
| 160 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07378968 |
| 161 | Salivary secretion_Homo sapiens_hsa04970 | 0.05544926 |
| 162 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02266680 |
| 163 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.00341196 |
| 164 | Focal adhesion_Homo sapiens_hsa04510 | -0.0037767 |

